Zetomipzomib (KZR-616) attenuates lupus in mice via modulation of innate and adaptive immune responses.

MLA

Muchamuel, Tony, et al. “Zetomipzomib (KZR-616) Attenuates Lupus in Mice via Modulation of Innate and Adaptive Immune Responses.” Frontiers in Immunology, vol. 14, Mar. 2023, pp. 1–17. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1043680.

APA

Muchamuel, T., Fan, R. A., Anderl, J. L., Bomba, D. J., Johnson, H. W. B., Lowe, E., Tuch, B. B., McMinn, D. L., Millare, B., & Kirk, C. J. (2023). Zetomipzomib (KZR-616) attenuates lupus in mice via modulation of innate and adaptive immune responses. Frontiers in Immunology, 14, 1–17. https://doi.org/10.3389/fimmu.2023.1043680

Chicago

Muchamuel, Tony, R. Andrea Fan, Janet L. Anderl, Darrin J. Bomba, Henry W. B. Johnson, Eric Lowe, Brian B. Tuch, Dustin L. McMinn, Beatriz Millare, and Christopher J. Kirk. 2023. “Zetomipzomib (KZR-616) Attenuates Lupus in Mice via Modulation of Innate and Adaptive Immune Responses.” Frontiers in Immunology 14 (March): 1–17. doi:10.3389/fimmu.2023.1043680.